Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Health Econ Policy Law ; 18(2): 111-120, 2023 04.
Artigo em Inglês | MEDLINE | ID: mdl-35801583

RESUMO

This paper documents changes in infant mortality (IM) rates in São Paulo, Brazil, between 2003 and 2013 and examines the association among neighborhood characteristics and IM. We investigate the extent to which increased use of health care services and improvements in economic and social conditions are associated with reductions in IM. Using data from the Brazilian Census and the São Paulo Secretaria Municipal da Saúde/SMS, we conducted a longitudinal analysis of panel data in all 96 districts of São Paulo for every year between 2003 and 2013. Our regression model includes district level measures that reflect economic, health care and social determinants of IM. We find that investments in health care have contributed to lower IM rates in the city, but the direct effect of increased spending is most evident for people living in São Paulo's middle- and high-income neighborhoods. Improvements in social conditions were more strongly associated with IM declines than increases in the use of health care among São Paulo's low-income neighborhoods. To reduce health inequalities, policies should target benefits to lower-income neighborhoods. Subsequent research should document the consequences of recent changes in Brazil's economic capacity and commitment to public health spending for population health.


Assuntos
Atenção à Saúde , Renda , Lactente , Humanos , Brasil/epidemiologia , Mortalidade Infantil , Serviços de Saúde
2.
Int J Health Policy Manag ; 7(3): 201-206, 2018 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-29524948

RESUMO

BRIC nations - Brazil, Russia, India, and China - represent 40% of the world's population, including a growing aging population and middle class with an increasing prevalence of chronic disease. Their healthcare systems increasingly rely on prescription drugs, but they differ from most other healthcare systems because healthcare expenditures in BRIC nations have exhibited the highest revenue growth rates for pharmaceutical multinational corporations (MNCs), Big Pharma. The response of BRIC nations to Big Pharma presents contrasting cases of how governments manage the tensions posed by rising public expectations and limited resources to satisfy them. Understanding these tensions represents an emerging area of research and an important challenge for all those who work in the field of health policy and management (HPAM).


Assuntos
Atenção à Saúde/organização & administração , Indústria Farmacêutica/economia , Política de Saúde , Brasil , China , Atenção à Saúde/economia , Gastos em Saúde/estatística & dados numéricos , Humanos , Índia , Medicamentos sob Prescrição/economia , Federação Russa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA